E-resources
-
Ravasio, Roberto; Girolomoni, Giampiero; Gorla, Roberto
Global & regional health technology assessment (Online), 01/2018, Volume: 2018Journal Article
Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis determine a high cost to the Italian National Health Service (INHS). The availability of biological drugs – among which etanercept – greatly improved treatment efficacy. The biological drugs are an expensive resource. Etanercept patent protection has expired, and biosimilar has been recently approved. Considering the perspective of the INHS, a drug budget impact (DBI) analysis was conducted to evaluate the consequences of the biosimilar availability in terms of cost containment (savings), thanks to its lower price compared to the originator’s. The DBI model expects that some patients in treatment with the originator will switch (uptake rate) to the biosimilar and that some naïve patients will directly start treatment with the biosimilar (uptake rate). Separately considering all the different diseases for which etanercept is indicated (Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis), the number of patients who might potentially use the biosimilar is estimated – based on disease prevalence and incidence rates, the overall proportion of treated patients and the etanercept market share. The time horizon extends to five years. The results from the analysis show (in the base case) that the availability of the biosimilar would provide overall annual savings over €25 million to the INHS in the fifth year, while the cumulated savings in the five years period would be about €90 million.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.